Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc (ACN) received a Rule 144 notice for a proposed sale of 9,000 Class A ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,278,350.00 and an approximate sale date of 10/29/2025.
The shares to be sold were acquired on 10/20/2025 via a stock award from the issuer in the same 9,000-share amount. As context, the filing lists 658,171,748 shares outstanding. The past three months section shows a sale by Julie Sweet of 9,000 Class A ordinary shares on 10/22/2025 for $2,246,165.10 in gross proceeds.
Accenture plc (ACN): Insider transaction filed. Ryoji Sekido, Co‑CEO Asia Pacific, reported open‑market sales totaling 2,500 Class A ordinary shares on 10/22/2025 pursuant to a Rule 10b5‑1 trading plan.
The sales were executed in three tranches: 494 shares at a weighted average price of $248.3699 (range $247.86–$248.65), 1,484 shares at $249.5688 (range $249.04–$249.96), and 522 shares at $250.2294 (range $250.07–$250.60). Following these transactions, the reporting person directly beneficially owns 1,390 shares.
Accenture plc (ACN) reported insider transactions by Chair and CEO Julie Sweet. On 10/22/2025, she sold 9,000 Class A ordinary shares in multiple tranches under a Rule 10b5-1 trading plan. Sales were executed at weighted average prices of $248.2045, $249.4098, $250.1299, and $250.869, with underlying trades spanning $247.82 to $250.98. Following these transactions, she beneficially owned 23,516 shares.
Accenture plc reported an insider transaction by its Chief Strategy & Services Officer, who sold 6,902 Class A ordinary shares on 10/22/2025. The sale was executed under a Rule 10b5-1 Trading Plan, indicating a pre-arranged, automated program. The weighted average sale price was $250.0068, with trades occurring between $250.00 and $250.42.
Following the transaction, the reporting person beneficially owns 1,860 shares, held directly. This filing documents a planned disposition and provides price transparency across multiple trade executions on the reported date.
ACN: A shareholder filed a Form 144 notice to sell up to 6,902 Class A Ordinary shares, with an aggregate market value of $1,725,500. UBS Financial Services is listed as broker, and the approximate sale date is 10/22/2025 on the NYSE.
The shares were acquired via stock awards on 11/15/2024 (19), 02/14/2025 (8), and 10/20/2025 (6,875). Shares outstanding were 658,171,748; this is a baseline figure, not the amount being offered.
Accenture plc (ACN) filed a Form 144 notice for a proposed sale of 2,500 Class A ordinary shares, reflecting an aggregate market value of $621,525.00. The shares are slated for sale on 10/22/2025 through UBS Financial Services Inc. on the NYSE. The seller acquired these shares on 10/20/2025 via a stock award from the issuer. As context, 658,171,748 shares were outstanding.
Accenture plc (ACN) filed a Form 144 indicating a proposed sale of 9,000 Class A Ordinary shares through UBS Financial Services on the NYSE. The filing lists an aggregate market value of $2,246,165.10 for the shares and notes an approximate sale date of 10/22/2025.
The shares were acquired on 10/20/2025 via a stock award from the issuer. As context, 658,171,748 shares were outstanding at the time cited in the notice. A Form 144 is a notice of intent to sell restricted or control securities and does not by itself guarantee that a sale will occur.
Accenture plc reported an insider transaction by its Chief Operating Officer. On 10/20/2025, the officer acquired 2,162 Class A ordinary shares at $0 (transaction code A) and disposed of 884 shares at $241.9625 (code F). Following these transactions, directly held shares were 10,034, with an additional 2,048 shares held indirectly in a Family Trust.
Accenture plc (ACN) reported an insider transaction by Chief Executive Officer-EMEA Mauro Macchi. On 10/20/2025, he acquired 3,863 Class A ordinary shares at $0 under transaction code A and disposed of 1,745 shares at $241.9625 under transaction code F. After the reported transactions, he directly beneficially owned 4,401 Class A ordinary shares.
Accenture plc (ACN) reported an insider transaction by officer Atsushi Egawa (Co-CEO Asia Pacific). On 10/20/2025, the reporting person acquired 3,863 Class A ordinary shares at a stated price of $0. Following the transaction, the reporting person beneficially owned 14,846 shares directly and 48 shares indirectly, held by an immediate family member.